Press Releases

Prof. Dr Christoph Hirneiß presents MINIject at DOC 2021 digital

The DOC (Deutsche Gesellschaft für Ophthalmochirurgie e.V.) are holding their 33rd International Congress of German Ophthalmic Surgeons as a digital event this year from 17 to 19 June 2021. The congress includes an extensive programme with scientific sessions on glaucoma surgery.

iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial

Growing body of evidence confirms MINIject is safe and effective with results sustained over time

Positive outcomes for iSTAR Medical’s MIGS MINIject shown in trials of over 130 glaucoma patients

Pooled data confirm excellent safety and efficacy profile with very low rate of reintervention

First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma

Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment.

iSTAR Medical announces EUR 40m Series C Financing

To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM WAVRE, Belgium — 5 September 2019:  iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced the completion of a €40m Series C financing. The financing was led by healthcare specialist funds LSP and Gimv, with participation […]